About CIRBA
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at CIRBA
During the past decade, CIRBA conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventional Care
2003-11-01
2007-07-01
Completed
358
Lumbar Interbody Fusion Using the Telamon® Peek™ Versus the Telamon® Hydrosorb™ Fusion Device
2004-10-01
2006-05-01
Terminated
102
Prevention of Relapses in Proteinase 3 (PR3)-Anti-neutrophil Cytoplasmic Antibodies (ANCA)-Associated Vasculitis
2003-06-01
2014-12-01
Terminated
131
The Viability-Guided Angioplasty After Acute Myocardial Infarction-Trial (The VIAMI-Trial)
2001-04-01
2007-01-01
Unknown status
300
Excitatory Amino Acids and Activated Microglia After Traumatic Brain Injury: a (R)-[11C]PK11195 PET Study
2001-05-01
2004-12-01
Unknown status
20
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "CIRBA"
#1 collaborator was "BIOLIM/FSS/UL, Lomé, Togo" with 1 trials as a collaborator, "CIRBA, Abidjan, Ivory Coast" with 1 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 1 trials as a collaborator, "Institut de Recherche pour le Developpement" with 1 trials as a collaborator and "SEREFO, Bamako, Mali" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were
collaborators in the rest 5 trials.
Clinical Trials Conditions at CIRBA
According to Clinical.Site data, the most researched conditions in "CIRBA" are
"COVID-19" (1 trials), "HIV Infections" (1 trials) and "HIV-2 Infection" (1 trials). Many other conditions were trialed in "CIRBA" in a lesser frequency.
Clinical Trials Intervention Types at CIRBA
Most popular intervention types in "CIRBA" are "Diagnostic Test" (1 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "RT PCR" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Lopinavir/ritonavir" (1 trials), "Tenofovir + Emtricitabine or Lamivudine + Raltegravir" (1 trials) and "Tenofovir + Emtricitabine or Lamivudine + Zidovudine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at CIRBA
The vast majority of trials in "CIRBA" are
3 trials for "All" genders.
Clinical Trials Status at CIRBA
Currently, there are NaN active trials in "CIRBA".
2 are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in CIRBA,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in CIRBA, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".